《独家新闻》中国艾兰得健康寻求买家，估值超过15亿美元--消息人士

路透中文

Aug 12

《独家新闻》中国艾兰得健康寻求买家，估值超过15亿美元--消息人士

路透新加坡8月12日 - 两位知情人士称，总部位于中国的全球营养补充剂制造商艾兰得健康控股(Aland Health Holding)的所有者正寻求出售他们的合并控股权，目标估值超过 15 亿美元。

消息人士称，创始人兼董事长常亮持有艾兰得约 60% 的股份，其余股份由 Affinity Equity Partners、Goldman Sachs Growth Equity 和 Henderson Investment Corp 等投资公司持有。

其中一位消息人士称，艾兰得今年的息税折旧摊销前利润 (EBITDA) 有望达到约 1.5 亿美元，已引起战略买家和私募股权公司的初步兴趣。

消息人士补充说，艾兰得在美国的业务由其子公司 International Vitamin Corporation $(IVC.AU)$推动，这对于寻求扩大国内生产并利用全球对健康和营养产品不断增长的需求的潜在竞购者来说是个重要的吸引点。

消息人士称，出售艾兰得健康的计划仍处于初期阶段，尚未设定邀请潜在竞购者进行非约束性投标的截止日期。由于此事尚未公开，两位消息人士均拒绝透露姓名。

艾兰得没有回应置评请求。

Affinity、Goldman 和 Henderson 均不予置评。

根据 Grand View Research 的数据，全球营养补充剂市场规模在 2024 年达到 4,856 亿美元，预计到 2030 年将达到 7,043 亿美元，复合年增长率为 6.4%。（完）

(编审白云)

((yun.bai@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2558611981"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2558611981\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2558611981?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-08-12 15:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2558611981","market":"us","top_or_hot":-1,"title":"《独家新闻》中国艾兰得健康寻求买家，估值超过15亿美元--消息人士","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>《独家新闻》中国艾兰得健康寻求买家，估值超过15亿美元--消息人士</title></head><body><p><span>路透新加坡8月12日</span><span> - </span>两位知情人士称，总部位于中国的全球营养补充剂制造商艾兰得健康控股(Aland Health Holding)的所有者正寻求出售他们的合并控股权，目标估值超过 15 亿美元。</p><p>消息人士称，创始人兼董事长常亮持有艾兰得约 60% 的股份，其余股份由 Affinity Equity Partners、Goldman Sachs Growth Equity 和 Henderson Investment Corp 等投资公司持有。</p><p>其中一位消息人士称，艾兰得今年的息税折旧摊销前利润 (EBITDA) 有望达到约 1.5 亿美元，已引起战略买家和私募股权公司的初步兴趣。</p><p>消息人士补充说，艾兰得在美国的业务由其子公司 International Vitamin Corporation <a href=\"https://laohu8.com/S/IVC.AU\">$(IVC.AU)$</a>推动，这对于寻求扩大国内生产并利用全球对健康和营养产品不断增长的需求的潜在竞购者来说是个重要的吸引点。</p><p> 消息人士称，出售艾兰得健康的计划仍处于初期阶段，尚未设定邀请潜在竞购者进行非约束性投标的截止日期。由于此事尚未公开，两位消息人士均拒绝透露姓名。</p><p>艾兰得没有回应置评请求。</p><p>Affinity、Goldman 和 Henderson 均不予置评。</p><p>根据 Grand View Research 的数据，全球营养补充剂市场规模在 2024 年达到 4,856 亿美元，预计到 2030 年将达到 7,043 亿美元，复合年增长率为 6.4%。（完）</p><p>(编审 白云)</p><p>((yun.bai@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《独家新闻》中国艾兰得健康寻求买家，估值超过15亿美元--消息人士</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《独家新闻》中国艾兰得健康寻求买家，估值超过15亿美元--消息人士\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2025-08-12 15:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>《独家新闻》中国艾兰得健康寻求买家，估值超过15亿美元--消息人士</title></head><body><p><span>路透新加坡8月12日</span><span> - </span>两位知情人士称，总部位于中国的全球营养补充剂制造商艾兰得健康控股(Aland Health Holding)的所有者正寻求出售他们的合并控股权，目标估值超过 15 亿美元。</p><p>消息人士称，创始人兼董事长常亮持有艾兰得约 60% 的股份，其余股份由 Affinity Equity Partners、Goldman Sachs Growth Equity 和 Henderson Investment Corp 等投资公司持有。</p><p>其中一位消息人士称，艾兰得今年的息税折旧摊销前利润 (EBITDA) 有望达到约 1.5 亿美元，已引起战略买家和私募股权公司的初步兴趣。</p><p>消息人士补充说，艾兰得在美国的业务由其子公司 International Vitamin Corporation <a href=\"https://laohu8.com/S/IVC.AU\">$(IVC.AU)$</a>推动，这对于寻求扩大国内生产并利用全球对健康和营养产品不断增长的需求的潜在竞购者来说是个重要的吸引点。</p><p> 消息人士称，出售艾兰得健康的计划仍处于初期阶段，尚未设定邀请潜在竞购者进行非约束性投标的截止日期。由于此事尚未公开，两位消息人士均拒绝透露姓名。</p><p>艾兰得没有回应置评请求。</p><p>Affinity、Goldman 和 Henderson 均不予置评。</p><p>根据 Grand View Research 的数据，全球营养补充剂市场规模在 2024 年达到 4,856 亿美元，预计到 2030 年将达到 7,043 亿美元，复合年增长率为 6.4%。（完）</p><p>(编审 白云)</p><p>((yun.bai@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0234572021.USD","symbol_name":"高盛美国核心股票组合Acc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL6S3U40AC:1","article_id":"2558611981","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2558611981","pubTimestamp":1754982639,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"《独家新闻》中国艾兰得健康寻求买家，估值超过15亿美元--消息人士路透新加坡8月12日 - 两位知情人士称，总部位于中国的全球营养补充剂制造商艾兰得健康控股的所有者正寻求出售他们的合并控股权，目标估值超过 15 亿美元。消息人士称，出售艾兰得健康的计划仍处于初期阶段，尚未设定邀请潜在竞购者进行非约束性投标的截止日期。艾兰得没有回应置评请求。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0234572021.USD":"高盛美国核心股票组合Acc","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU0385154629.USD":"贝莱德营养科学基金A2","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","LU1035773651.USD":"AB SICAV I - GLOBAL VALUE PORTFOLIO \"AD\" (USD) INC","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU2125154778.USD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (USD) INC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","LU1267930490.SGD":"TEMPLETON GLOBAL EQUITY INCOME \"AS\" (SGD) INC A","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","00012":"恒基地产","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","IE0004086264.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"A\" (USD) ACC","LU2505996509.AUD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (AUDHDG) INC","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","BK4127":"投资银行业与经纪业","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","LU0553294199.USD":"BGF GLOBAL EQUITY INCOME \"A5G\" (USD) INC","LU1496350502.SGD":"FRANKLIN DIVERSIFIED DYNAMIC \"A\" (SGDHDG) ACC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","LU0079474960.USD":"联博美国增长基金A","LU2168564495.EUR":"AZ ALLOCATION - TREND \"AI\" (EUR) ACC","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","BK1122":"百货商店","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU2381873111.SGD":"BGF SYSTEMATIC GLOBAL EQUITY HIGH INCOME \"A6\" (SGDHDG) INC","LU0251142724.SGD":"Fidelity America A-SGD","LU2168564065.EUR":"AZ ALLOCATION - TREND \"AAZ\" (EUR) ACC","BK4588":"碎股","BK4550":"红杉资本持仓","00097":"恒基发展","LU2471134796.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) INC","LU2168563687.JPY":"AZ ALLOCATION - TREND \"AAZ\" (JPYHDG) ACC"},"translate_title":"\"Scoop\" China's Aland Health seeks buyers, valued at more than $1.5 billion--sources","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00012":0.9,"00097":0.9},"content_text":"《独家新闻》中国艾兰得健康寻求买家，估值超过15亿美元--消息人士路透新加坡8月12日 - 两位知情人士称，总部位于中国的全球营养补充剂制造商艾兰得健康控股(Aland Health Holding)的所有者正寻求出售他们的合并控股权，目标估值超过 15 亿美元。消息人士称，创始人兼董事长常亮持有艾兰得约 60% 的股份，其余股份由 Affinity Equity Partners、Goldman Sachs Growth Equity 和 Henderson Investment Corp 等投资公司持有。其中一位消息人士称，艾兰得今年的息税折旧摊销前利润 (EBITDA) 有望达到约 1.5 亿美元，已引起战略买家和私募股权公司的初步兴趣。消息人士补充说，艾兰得在美国的业务由其子公司 International Vitamin Corporation $(IVC.AU)$推动，这对于寻求扩大国内生产并利用全球对健康和营养产品不断增长的需求的潜在竞购者来说是个重要的吸引点。 消息人士称，出售艾兰得健康的计划仍处于初期阶段，尚未设定邀请潜在竞购者进行非约束性投标的截止日期。由于此事尚未公开，两位消息人士均拒绝透露姓名。艾兰得没有回应置评请求。Affinity、Goldman 和 Henderson 均不予置评。根据 Grand View Research 的数据，全球营养补充剂市场规模在 2024 年达到 4,856 亿美元，预计到 2030 年将达到 7,043 亿美元，复合年增长率为 6.4%。（完）(编审 白云)((yun.bai@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}